1. Home
  2. SBR vs WVE Comparison

SBR vs WVE Comparison

Compare SBR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBR
  • WVE
  • Stock Information
  • Founded
  • SBR 1982
  • WVE 2012
  • Country
  • SBR United States
  • WVE Singapore
  • Employees
  • SBR N/A
  • WVE N/A
  • Industry
  • SBR Oil & Gas Production
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SBR Energy
  • WVE Health Care
  • Exchange
  • SBR Nasdaq
  • WVE Nasdaq
  • Market Cap
  • SBR 1.1B
  • WVE 915.6M
  • IPO Year
  • SBR N/A
  • WVE 2015
  • Fundamental
  • Price
  • SBR $78.75
  • WVE $7.09
  • Analyst Decision
  • SBR
  • WVE Strong Buy
  • Analyst Count
  • SBR 0
  • WVE 14
  • Target Price
  • SBR N/A
  • WVE $20.50
  • AVG Volume (30 Days)
  • SBR 35.7K
  • WVE 3.7M
  • Earning Date
  • SBR 01-01-0001
  • WVE 11-10-2025
  • Dividend Yield
  • SBR 6.79%
  • WVE N/A
  • EPS Growth
  • SBR N/A
  • WVE N/A
  • EPS
  • SBR 5.44
  • WVE N/A
  • Revenue
  • SBR $83,430,550.00
  • WVE $109,230,000.00
  • Revenue This Year
  • SBR N/A
  • WVE N/A
  • Revenue Next Year
  • SBR N/A
  • WVE $6.24
  • P/E Ratio
  • SBR $14.54
  • WVE N/A
  • Revenue Growth
  • SBR N/A
  • WVE 103.75
  • 52 Week Low
  • SBR $58.25
  • WVE $5.28
  • 52 Week High
  • SBR $84.39
  • WVE $16.38
  • Technical
  • Relative Strength Index (RSI)
  • SBR 71.44
  • WVE 43.50
  • Support Level
  • SBR $71.35
  • WVE $6.72
  • Resistance Level
  • SBR $73.38
  • WVE $8.08
  • Average True Range (ATR)
  • SBR 2.13
  • WVE 0.73
  • MACD
  • SBR 0.90
  • WVE -0.13
  • Stochastic Oscillator
  • SBR 97.11
  • WVE 17.44

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: